• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氟尿嘧啶的结肠给药:体外评价

Colonic drug delivery of 5-fluorouracil: an in vitro evaluation.

作者信息

Sinha V R, Mittal B R, Bhutani K K, Kumria Rachna

机构信息

University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160 014, India.

出版信息

Int J Pharm. 2004 Jan 9;269(1):101-8. doi: 10.1016/j.ijpharm.2003.09.036.

DOI:10.1016/j.ijpharm.2003.09.036
PMID:14698581
Abstract

Compression coating has been found to be useful for colonic drug delivery. The aim of the present investigation was to design a formulation with a considerably reduced coat weight and gum concentration for colonic delivery of 5-fluorouracil for the treatment of colorectal cancer. Rapidly disintegrating core tablets containing 50 mg of 5-fluorouracil were prepared and compression coating with 175 mg of granules containing a mixture of xanthan gum (XG) and guar gum (GG) in varying proportions was done. With this coat weight, a highly retarded drug release was observed. After 24h of dissolution the mean percent drug release from the compression coated XG:GG 20:20, 20:10 and 10:20 tablets were found to be around 18+/-1.23%, 20+/-1.54% and 30+/-1.77%, respectively. So, the coat weight was further reduced to 150 mg. It was observed that reduction of coat weight did not affect the initial drug release rate in simulated upper gastrointestinal tract (GIT) conditions. At the end of 24h of dissolution the amount of drug released increased to 25+/-1.22%, 36.6+/-1.89% and 42.6+/-2.22%, respectively in XG:GG 20:20, 20:10 and 10:20 tablets. Studies of XG:GG (10:20) tablets in presence of colonic contents showed an increased cumulative percent drug release of 67.2+/-5.23% in presence of 2% cecal content and 80.34+/-3.89% in presence of 4% cecal content after 19 h of incubation.

摘要

已发现压制包衣对结肠给药有用。本研究的目的是设计一种包衣重量和胶浓度显著降低的制剂,用于结肠递送5-氟尿嘧啶以治疗结直肠癌。制备了含50mg 5-氟尿嘧啶的快速崩解片芯,并对其进行压制包衣,包衣材料为175mg含有不同比例黄原胶(XG)和瓜尔胶(GG)混合物的颗粒。在这种包衣重量下,观察到药物释放高度延迟。在溶出24小时后,发现压制包衣的XG:GG 20:20、20:10和10:20片剂的平均药物释放百分比分别约为18±1.23%、20±1.54%和30±1.77%。因此,将包衣重量进一步降低至150mg。观察到包衣重量的降低并不影响模拟上消化道(GIT)条件下的初始药物释放速率。在溶出24小时结束时,XG:GG 20:20、20:10和10:20片剂中的药物释放量分别增加到25±1.22%、36.6±1.89%和42.6±2.22%。在结肠内容物存在的情况下对XG:GG(10:20)片剂进行的研究表明,在孵育19小时后,在2%盲肠内容物存在的情况下,药物累积释放百分比增加到67.2±5.23%,在4%盲肠内容物存在的情况下增加到80.34±3.89%。

相似文献

1
Colonic drug delivery of 5-fluorouracil: an in vitro evaluation.5-氟尿嘧啶的结肠给药:体外评价
Int J Pharm. 2004 Jan 9;269(1):101-8. doi: 10.1016/j.ijpharm.2003.09.036.
2
Compression coated systems for colonic delivery of 5-fluorouracil.用于结肠递送5-氟尿嘧啶的包衣压缩系统。
J Pharm Pharmacol. 2007 Mar;59(3):359-65. doi: 10.1211/jpp.59.3.0004.
3
Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.果胶/乙基纤维素作为结肠靶向给药的薄膜包衣:以5-氟尿嘧啶微丸为例的制备及体外评价
PDA J Pharm Sci Technol. 2007 Mar-Apr;61(2):121-30.
4
In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.用于结肠特异性药物递送的多糖片崩解时间和部位的体内评价。
Int J Pharm. 2005 Jan 31;289(1-2):79-85. doi: 10.1016/j.ijpharm.2004.10.019. Epub 2004 Dec 25.
5
In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil.基于瓜尔胶的5-氟尿嘧啶结肠靶向口服给药系统的体外药物释放研究。
Eur J Pharm Sci. 2002 Aug;16(3):185-92. doi: 10.1016/s0928-0987(02)00081-7.
6
Polysaccharide matrices for microbially triggered drug delivery to the colon.用于微生物触发药物递送至结肠的多糖基质。
Drug Dev Ind Pharm. 2004 Feb;30(2):143-50. doi: 10.1081/ddc-120028709.
7
Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis.用于治疗阿米巴病的甲硝唑口服结肠靶向给药系统的开发研究。
Int J Pharm. 2002 Apr 2;236(1-2):43-55. doi: 10.1016/s0378-5173(02)00006-6.
8
Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis.用于治疗阿米巴病的奥硝唑结肠靶向口服给药系统的研发研究。
Drug Deliv. 2003 Apr-Jun;10(2):111-7. doi: 10.1080/713840359.
9
Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.羟丙基甲基纤维素压制包衣片中5-氟尿嘧啶释放特性的研究
Pharm Dev Technol. 2007;12(2):203-10. doi: 10.1080/10837450601168722.
10
Design and in vitro evaluation of oral colon targeted drug delivery systems for tinidazole.替硝唑口服结肠靶向给药系统的设计与体外评价
J Drug Target. 2002 Dec;10(8):579-84. doi: 10.1080/1061186021000072690.

引用本文的文献

1
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展:创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
2
A Comprehensive Review of Xanthan Gum-Based Oral Drug Delivery Systems.基于黄原胶的口服药物传递系统的全面综述。
Int J Mol Sci. 2024 Sep 21;25(18):10143. doi: 10.3390/ijms251810143.
3
Formulation of a thermo-sensitive hydro-gel for ulcerative colitis treatment.
用于溃疡性结肠炎治疗的热敏水凝胶的配方。
Bioinformation. 2022 Oct 31;18(10):925-937. doi: 10.6026/97320630018925. eCollection 2022.
4
Development and optimization of nanoparticles loaded with erucin, a dietary isothiocyanate isolated from Antioxidant and antiproliferative activities in ehrlich-ascites carcinoma cell line.从埃氏腹水癌细胞系中分离出的一种膳食异硫氰酸酯——芥酸装载纳米颗粒的开发与优化。抗氧化及抗增殖活性
Front Pharmacol. 2023 Jan 25;13:1080977. doi: 10.3389/fphar.2022.1080977. eCollection 2022.
5
Methotrexate-Loaded Gelatin and Polyvinyl Alcohol (Gel/PVA) Hydrogel as a pH-Sensitive Matrix.负载甲氨蝶呤的明胶与聚乙烯醇(Gel/PVA)水凝胶作为一种pH敏感型基质
Polymers (Basel). 2021 Jul 14;13(14):2300. doi: 10.3390/polym13142300.
6
pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.用于口服给药的pH响应型载体:当前平台面临的挑战与机遇
Drug Deliv. 2017 Nov;24(1):569-581. doi: 10.1080/10717544.2017.1279238.
7
A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media.一种用于测试基于纳米结构多糖的结肠特异性药物递送系统药物释放的新型溶出介质:替代结肠介质的方法。
Int J Nanomedicine. 2016 Mar 17;11:1089-95. doi: 10.2147/IJN.S97177. eCollection 2016.
8
Coated chitosan nanoparticles encapsulating caspase 3 activator for effective treatment of colorectral cancer.包被壳聚糖纳米粒的 caspase-3 激活剂用于结直肠癌的有效治疗。
Drug Deliv Transl Res. 2015 Dec;5(6):596-610. doi: 10.1007/s13346-015-0255-x.
9
Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.结肠靶向压缩包衣片:包衣和片芯材料对药物释放的影响
AAPS PharmSciTech. 2016 Apr;17(2):504-15. doi: 10.1208/s12249-015-0359-0. Epub 2015 Aug 14.
10
Preparation and In vitro Investigation of Chitosan Compressed Tablets for Colon Targeting.用于结肠靶向的壳聚糖压制片的制备及体外研究
Adv Pharm Bull. 2011;1(2):87-92. doi: 10.5681/apb.2011.013. Epub 2011 Dec 15.